🧬 biology

Chemical Barrier Modulation by Bile Salts Drives Spatially Resolved Viscoelastic Reconfiguration in Buccal Epithelia

This study demonstrates that the bile salt sodium glycodeoxycholate modulates chemical barriers in buccal epithelia by inducing molecular membrane reorganisation that drives spatially resolved viscoelastic reconfiguration, revealing that permeation enhancement relies on transient epithelial state transitions rather than simple barrier opening.

Original authors: David Brayden, Sahil Malhotra, Holly Linford, Shakhawath Hossain, Muhammad Ijaz, Estela Bini, Sandeep Karki, Christel Bergström, Arun Kumar, Antonio Benedetto

Published 2026-07-10

📖 6 min read🧠 Deep dive

CC BY 4.0

Original authors: David Brayden, Sahil Malhotra, Holly Linford, Shakhawath Hossain, Muhammad Ijaz, Estela Bini, Sandeep Karki, Christel Bergström, Arun Kumar, Antonio Benedetto

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Imagine your cheek lining (the buccal epithelium) not just as a wall, but as a bouncy, stretchy trampoline made of tiny, sticky cells. Its job is to keep the outside world out while letting your body do its thing. Now, imagine trying to sneak a medicine molecule (like a peptide) through this trampoline. Usually, it's too tough. But what if you could temporarily turn that trampoline into a super-soft, squishy gel that lets the medicine slip right through?

That's exactly what this study explores using a substance called sodium glycodeoxycholate (GDC), a type of bile salt.

The Big Reveal: It's Not Just "Breaking" the Wall

For a long time, scientists thought permeation enhancers (the "keys" that open the door for drugs) worked by simply punching holes in the cell wall or making the whole membrane uniformly watery and loose.

This paper argues against that simple idea. Instead, it suggests that GDC doesn't just break the wall; it reprograms the mechanical personality of the tissue. It changes how the cells feel, move, and bounce back. The authors found that GDC makes the cells act more like a dissipating sponge than a rigid brick.

The Evidence: From Tiny Cells to Whole Tissue

1. The Squishy Cell Test (Human Cells)
The researchers looked at human cheek cells (called TR146) under a super-sensitive microscope called an Atomic Force Microscope (AFM), which acts like a tiny, super-fast finger poking the cells.

The Result: When they poked cells treated with a high dose of GDC (2 mM), the cells felt much softer. Their "stiffness" (Young's modulus) dropped from a median of about 238 Pa in normal cells to less than 50 Pa.
The Bounce: Normal cells bounce back quickly. GDC-treated cells relaxed their stress much faster. The "fast relaxation time" (τ₁) dropped from 0.162 s to 0.107 s, and the "slow relaxation time" (τ₂) dropped from 2.79 s to 1.74 s.
The Deformation: When pushed with the same force, normal cells squished down about 1.48 ± 0.45 μm. The GDC-treated cells squished way more, down 3.71 ± 1.45 μm.
What it means: The cells didn't just get weaker; they became better at absorbing energy and letting go of it. It's like switching from a stiff rubber band to a piece of warm taffy.

2. The "Doors" Moved (DSG-3)
Cells hold hands using special proteins called desmosomes (specifically a protein called DSG-3). In normal cells, these proteins form a neat fence along the edges.

The Change: After GDC treatment, these "hand-holding" proteins started gathering in little dots inside the cell, especially near the center (the nucleus), rather than staying in a neat line at the borders. This suggests the cells are rearranging their internal furniture to become softer.

3. The Real Tissue Puzzle (Pig Cheeks)
Real tissue is messy and uneven, unlike the neat lab cells. The researchers tested this on fresh pig cheek tissue (which is very similar to human tissue).

The Surprise: They didn't find a uniform softening. Instead, they found a spatially heterogeneous (patchy) response.
The Rule: If a spot on the tissue was already very stiff, GDC made it softer. But if a spot was already soft, GDC sometimes made it slightly stiffer!
The Takeaway: GDC doesn't just "melt" everything. It redistributes the mechanical stress based on what the tissue was doing before. It's like a smart thermostat that cools down hot rooms but warms up cold ones to find a balance.

The Molecular Magic: What's Happening Inside?

To understand why this happens, the team used computer simulations (Coarse-Grained Molecular Dynamics) to watch how GDC molecules interact with the cell's lipid (fat) layer.

The Simulation: They built a model of the cell membrane with 12,112 lipids and simulated it for 6 μs.
The Discovery: GDC molecules stuck to the surface of the fat layer but didn't dive deep. They messed up the orderly arrangement of the fat tails right at the surface.
- The "order" of the fat tails dropped from 0.626 ± 0.125 to 0.521 ± 0.107.
- The surface became rougher, jumping from 0.76 ± 0.05 nm to 1.34 ± 0.06 nm.
- The fat tails started wiggling faster (correlation time dropped from 38.5 ± 9.7 μs to 26.4 ± 6.6 μs).
The Energy Barrier: The team calculated the energy needed for a drug molecule (octreotide) to jump into the membrane. In the presence of GDC, this energy barrier dropped. The "rougher," messier surface made it easier for the drug to slip in.

The Final Test: Does the Medicine Actually Get Through?

The most exciting part: Does this mechanical change actually help drugs move?

The Experiment: They treated pig tissue with GDC for 30 or 60 minutes, then washed the GDC away completely. Only after washing did they add the drug (octreotide).
The Result: Even without GDC present, the drug moved through much faster!
- After 30 minutes of GDC, the drug flux was about 22 μg cm⁻² h⁻¹.
- After 60 minutes of GDC, the flux jumped to about 43 μg cm⁻² h⁻¹.
The Conclusion: The GDC didn't just carry the drug; it left the tissue in a "transport-permissive" state. The tissue stayed soft and open for a while after the GDC was gone.

What This Means for the Future

This study suggests that permeation enhancers work by reconfiguring the mechanical state of the tissue, not just by breaking it open. It implies that we might be able to use short "pulses" of enhancers to open the door, let the medicine in, and then let the door close again, rather than keeping the door wide open all the time.

However, the authors are careful to note that their computer simulations didn't include all the complex proteins found in real cells, so the full picture is still being pieced together. But the idea that we can measure the "squishiness" of cells to understand how drugs get in is a brand new, exciting way to look at drug delivery.

Technical Summary: Chemical Barrier Modulation by Bile Salts Drives Spatially Resolved Viscoelastic Reconfiguration in Buccal Epithelia

Problem Statement
While chemical permeation enhancers (PEs), particularly bile salts, are known to increase the permeability of oromucosal epithelia for peptide delivery, the underlying physical mechanisms remain unresolved. Conventional understanding relies on payload permeability outcomes (e.g., solute flux, TEER) or the concept of uniform membrane fluidization. However, it is unclear how epithelial physical states—specifically viscoelasticity and nanoscale mechanical organization—are reconfigured during transport modulation. Existing studies often lack spatial resolution, rely on fixed tissues that alter mechanical properties, or fail to link molecular lipid reorganization to tissue-level biomechanical changes under physiological conditions.

Methodology
The study employed a multiscale approach integrating experimental biophysics, molecular modeling, and functional permeation assays:

Cellular Level: Atomic Force Microscopy (AFM) was used on human TR146 buccal epithelial cells to quantify Young's modulus, stress relaxation times ( $\tau_1, \tau_2$ ), and maximum indentation following exposure to sodium glycodeoxycholate (GDC) at varying concentrations (1 mM, 2 mM). Immunofluorescence assessed the spatial redistribution of the desmosomal cadherin DSG-3.
Tissue Level: AFM nanomechanical mapping was performed on isolated, hydrated porcine buccal mucosae (ex vivo) to resolve spatial heterogeneity in stiffness before and after GDC exposure (30 mM).
Molecular Level: Coarse-grained Molecular Dynamics (CG-MD) simulations (Martini 3 force field) modeled a multilamellar buccal lipid assembly to investigate GDC-induced interfacial lipid reorganization, order parameters, and dynamics. Umbrella sampling simulations calculated the Potential of Mean Force (PMF) for octreotide insertion.
Functional Level: Ex vivo permeation studies using Franz diffusion cells and custom Transwell-mimicking inserts evaluated octreotide transport following transient GDC pre-exposure (with enhancer removal) to distinguish between co-transport and persistent epithelial state changes. Transepithelial Electrical Resistance (TEER) and fluorescence imaging of FD-4 were used to monitor barrier integrity and spatial transport.

Key Results

Viscoelastic Modulation in Cells: In TR146 cells, high-concentration GDC (2 mM) induced a significant mechanical softening, reducing the median Young's modulus to <50 Pa (from ~238 Pa in controls). This was accompanied by accelerated stress dissipation (reduced relaxation times $\tau_1$ and $\tau_2$ ) and increased maximum indentation. These changes were distinct from those caused by EDTA-induced junctional disruption, suggesting GDC acts via membrane reorganization and membrane-cortex coupling rather than solely junctional disruption.
DSG-3 Redistribution: GDC exposure caused a shift in DSG-3 from continuous junctional borders to a punctate, perinuclear intracellular pattern, particularly at 2 mM. This structural reorganization preceded or coincided with mechanical softening.
Spatial Heterogeneity in Tissue: In native porcine mucosae, GDC did not induce uniform softening. Instead, it caused a spatially heterogeneous, directionally biased redistribution of mechanical states: initially stiff regions predominantly softened, while the most compliant regions tended to stiffen. This indicates that the mechanical response is baseline-dependent and governed by local microstructure.
Molecular Mechanism: CG-MD simulations revealed that GDC inserts at the water-lipid interface, reducing lipid tail order parameters, accelerating lipid tail correlation times, and increasing interfacial roughness. These changes were confined to the interfacial leaflet, leaving deeper layers largely disordered. The simulations indicated that GDC lowers the energetic barrier for peptide (octreotide) insertion into the membrane.
Functional Persistence: Transient exposure to GDC (30–60 min) followed by its removal was sufficient to enhance subsequent octreotide flux. The enhanced transport persisted without the continuous presence of the enhancer, and the degree of flux enhancement correlated with the extent of early TEER reduction, not with the amount of GDC transported.

Key Contributions

Viscoelasticity as a Mechanistic Readout: The study establishes epithelial viscoelasticity (stiffness, stress relaxation, deformability) as a measurable feature of chemical barrier modulation, moving beyond simple "barrier opening" models.
Spatially Resolved Mechanics: It demonstrates that bile salt action is spatially heterogeneous and dependent on the baseline mechanical state of the tissue, rather than a uniform fluidization.
Molecular-Mechanical Link: It connects interfacial lipid disorder and hydration changes observed in simulations to macroscopic tissue softening and accelerated stress dissipation.
Transient State Transition: It provides evidence that PEs like GDC induce a transient, transport-permissive epithelial state that persists after enhancer removal, decoupling enhancer exposure from therapeutic dosing.

Significance and Claims
The authors claim that this work redefines the mechanism of permeation enhancement by bile salts. Rather than acting through simple, uniform membrane disruption, GDC induces a "mechanically coherent transition" characterized by enhanced viscoelastic dissipation and spatially reconfigured mechanical states. This reprogramming of the epithelial mechanical state lowers energetic barriers for peptide entry.

The study positions epithelial biomechanics as a critical tool for the mechanistic evaluation of barrier modulation. It suggests that future formulation strategies could leverage transient epithelial preconditioning (separating enhancer exposure from drug release) to improve peptide delivery while potentially minimizing cumulative enhancer dosing and preserving barrier integrity. The authors note that while their CG-MD models isolated lipid effects, the framework may extend to other amphiphilic permeation enhancers used in oral peptide formulations.

The Big Reveal: It's Not Just "Breaking" the Wall

The Evidence: From Tiny Cells to Whole Tissue

The Molecular Magic: What's Happening Inside?

The Final Test: Does the Medicine Actually Get Through?

What This Means for the Future

More like this